Capstone Therapeutics Corp. (CAPS)
(Real Time Quote from BATS)
$1.41 USD
+0.01 (0.71%)
Updated Aug 6, 2025 01:42 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CAPS 1.41 +0.01(0.71%)
Will CAPS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAPS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAPS
Capstone Holding (CAPS) Launches Corporate Development Team to Boost Acquisitions
Capstone announces formation of Corporate Development team
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate ...
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate Development Team
Capstone Therapeutics (CAPS) Plans to Sell Over 4 Million Common Shares